Cargando…

At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization

Refolding is known as the bottleneck in inclusion body (IB) downstream processing in the pharmaceutical industry: high dilutions leading to large operating volumes, slow refolding kinetics and low refolding yields are only a few of the problems that impede industrial application. Solubilization prio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebner, Julian, Humer, Diana, Klausser, Robert, Rubus, Viktor, Pell, Reinhard, Spadiut, Oliver, Kopp, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228044/
https://www.ncbi.nlm.nih.gov/pubmed/34200471
http://dx.doi.org/10.3390/bioengineering8060078
_version_ 1783712650196156416
author Ebner, Julian
Humer, Diana
Klausser, Robert
Rubus, Viktor
Pell, Reinhard
Spadiut, Oliver
Kopp, Julian
author_facet Ebner, Julian
Humer, Diana
Klausser, Robert
Rubus, Viktor
Pell, Reinhard
Spadiut, Oliver
Kopp, Julian
author_sort Ebner, Julian
collection PubMed
description Refolding is known as the bottleneck in inclusion body (IB) downstream processing in the pharmaceutical industry: high dilutions leading to large operating volumes, slow refolding kinetics and low refolding yields are only a few of the problems that impede industrial application. Solubilization prior to refolding is often carried out empirically and the effects of the solubilizate on the subsequent refolding step are rarely investigated. The results obtained in this study, however, indicate that the quality of the IB solubilizate has a severe effect on subsequent refolding. As the solubilizate contains chaotropic reagents in high molarities, it is commonly analyzed with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE, however, suffers from a long analysis time, making at-line analytical implementation difficult. In this study, we established an at-line reversed phase liquid chromatography method to investigate the time-dependent quality of the solubilizate. To verify the necessity of at-line solubilization monitoring, we varied the essential solubilization conditions for horseradish peroxidase IBs. The solubilization time was found to have a major influence on subsequent refolding, underlining the high need for an at-line analysis of solubilization. Furthermore, we used the developed reversed phase liquid chromatography method for an in-process control (IPC). In conclusion, the presented reversed phase liquid chromatography method allows a proper control of IB solubilization applicable for tailored refolding.
format Online
Article
Text
id pubmed-8228044
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82280442021-06-26 At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization Ebner, Julian Humer, Diana Klausser, Robert Rubus, Viktor Pell, Reinhard Spadiut, Oliver Kopp, Julian Bioengineering (Basel) Article Refolding is known as the bottleneck in inclusion body (IB) downstream processing in the pharmaceutical industry: high dilutions leading to large operating volumes, slow refolding kinetics and low refolding yields are only a few of the problems that impede industrial application. Solubilization prior to refolding is often carried out empirically and the effects of the solubilizate on the subsequent refolding step are rarely investigated. The results obtained in this study, however, indicate that the quality of the IB solubilizate has a severe effect on subsequent refolding. As the solubilizate contains chaotropic reagents in high molarities, it is commonly analyzed with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE, however, suffers from a long analysis time, making at-line analytical implementation difficult. In this study, we established an at-line reversed phase liquid chromatography method to investigate the time-dependent quality of the solubilizate. To verify the necessity of at-line solubilization monitoring, we varied the essential solubilization conditions for horseradish peroxidase IBs. The solubilization time was found to have a major influence on subsequent refolding, underlining the high need for an at-line analysis of solubilization. Furthermore, we used the developed reversed phase liquid chromatography method for an in-process control (IPC). In conclusion, the presented reversed phase liquid chromatography method allows a proper control of IB solubilization applicable for tailored refolding. MDPI 2021-06-07 /pmc/articles/PMC8228044/ /pubmed/34200471 http://dx.doi.org/10.3390/bioengineering8060078 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ebner, Julian
Humer, Diana
Klausser, Robert
Rubus, Viktor
Pell, Reinhard
Spadiut, Oliver
Kopp, Julian
At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization
title At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization
title_full At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization
title_fullStr At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization
title_full_unstemmed At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization
title_short At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization
title_sort at-line reversed phase liquid chromatography for in-process monitoring of inclusion body solubilization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228044/
https://www.ncbi.nlm.nih.gov/pubmed/34200471
http://dx.doi.org/10.3390/bioengineering8060078
work_keys_str_mv AT ebnerjulian atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization
AT humerdiana atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization
AT klausserrobert atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization
AT rubusviktor atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization
AT pellreinhard atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization
AT spadiutoliver atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization
AT koppjulian atlinereversedphaseliquidchromatographyforinprocessmonitoringofinclusionbodysolubilization